CLINICAL_TRIALS ClinicalTrials.gov record update

Correlation Between Homologous Recombination Deficiency Status and Resistance to PARP Inhibitors in Chinese Epithelial Ovarian Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05310370
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:43.918108+00:00
Published At: 2022-04-04T00:00:00+00:00
Record Updated At: 2022-04-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Epithelial Ovarian Cancer", "Homologous Recombination Deficiency", "Homologous Recombination Repair Gene Mutation", "Poly(ADP-ribose) Polymerase Inhibitor", "Drug Resistance", "Progression-free Survival", "Overall Survival"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-04-04"
protocolSection.identificationModule.nctId: "NCT05310370"
protocolSection.identificationModule.officialTitle: "Correlation Between Homologous Recombination Deficiency Status and Resistance to PARP Inhibitors in Chinese Epithelial Ovarian Cancer Patients"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.